Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RIBECCA: Ribociclib + Letrozole in HR+/HER2- Advanced Breast Cancer
NCT03096847Phase 3Completed
- Sponsor
- Novartis
- Start
- Oct 2016
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ribociclib in breast cancer, sponsored by Novartis. Started Oct 2016; status: completed.
02
Drugs
ribociclib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT03096847.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03096847.